Ignite Creation Date:
2024-05-06 @ 8:03 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06233110
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-11
First Post:
2024-01-22
Brief Title:
Ruxolitinib Plus Fostamatinib for Steroid Refractory CGvHD
Sponsor:
Stefanie Sarantopoulos MD PhD
Organization:
Duke University
Organization Data
Organization:
Duke University
Class:
OTHER
Study ID:
Pro00113327
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Stefanie Sarantopoulos MD PhD
Lead Sponsor Class:
OTHER
Responsible Party:
Stefanie Sarantopoulos MD PhD
Responsible Party Title:
Professor of Medicine
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Duke University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Incyte Corporation | INDUSTRY |
| Rigel Pharmaceuticals | INDUSTRY |
| National Institutes of Health NIH | NIH |